Urotensin II in Chronic Kidney Diseases and Kidney Transplants

Completed

• Conditions: Chronic Renal Disease

• Registration Number: NCT01098799
• Lead Sponsor: Vakif Gureba Training and Research Hospital

Brief Summary

The investigators are planning to study the serum level of Urotensin II in chronic kidney disease patients, kidney transplants, and healthy controls.

Detailed Description

The investigators will determine the urotensin II levels in Chronic kidney disease patients, kidney transplants, and healthy controls.

Study Timeline

• Study Start: 2010-04
• Study First Submitted: 2010-04-02
• Study First Submitted QC: 2010-04-02
• Study First Posted: 2010-04-05
• Primary Completion: 2010-07
• Study Completion: 2010-07
• Status Verified: 2013-06
• Last Update Submitted: 2013-06-12
• Last Update Posted: 2013-06-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

• Age more than 18

Exclusion Criteria

• Inability to give a written consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
serum Urotensin II(UII)level	at enrollment	We tried to compare UII level in normal, chronic kidney disease and kidney transplant patients group

Trial Locations

Locations (1)

Vakif Gureba Training & Research Hospital; 🇹🇷 Istanbul, Turkey